Evaluation of the Vulnerable Carotid Atherosclerotic Plaque: A Clinical Multicenter Study
NCT ID: NCT05849909
Last Updated: 2023-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
57 participants
OBSERVATIONAL
2023-04-18
2024-04-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chinese Multi-provincial Cohort Study-Beijing Project
NCT04253054
Early Vascular Wall Changes by Magnetic Resonance Imaging (MRI) in Metabolic Syndrome Versus Metabolically Normal Pre-Menopausal Women: A Pilot Study
NCT01068535
A Study of Chinese Adults With Lymphoma
NCT05288491
Large-scale Multi-omics Analysis of Cerebrospinal Fluid
NCT06636201
Brain Network Connectivity of Patients With Metabolic Diseases
NCT06725589
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stable Carotid Atherosclerotic Plaques
No interventions assigned to this group
Unstable Carotid Atherosclerotic Plaques
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age\>18 years old;
3. Patients who sign informed consent forms
Exclusion Criteria
2. Contraindications to ultrasound contrast, such as those who are allergic to contrast agents;
3. Intracardiac right to left shunt;
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
huang pintong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
huang pintong
Director of Ultrasound Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Ultrasound, Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-0402
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.